Clin Mol Hepatol.
2025 Jan;31(1):e90-e92. 10.3350/cmh.2024.0998.
Correspondence to editorial on “Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma”
- Affiliations
-
- 1Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China
- 2Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
- KMID: 2563469
- DOI: http://doi.org/10.3350/cmh.2024.0998
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Stroma-tology: Predicting recurrence in cholangiocarcinoma: Editorial on “Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma”
- Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma
- Identification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer
- Review: Analysis of Survival Rate and Prognostic Factors of Intrahepatic Cholangiocarcinoma: 318 Cases in Single Institute
- Image Findings of Sarcomatous Intrahepatic Cholangiocarcinoma Focused on Gd-EOB-DTPA Enhanced MRI: A Case Report
